How Pharmacogenomics Informs and Influences the Medication Experience

Anthony W Olson; Jacob T Brown

doi:10.24926/iip.v14i4.5796

How Pharmacogenomics Informs and Influences the Medication Experience

Innov Pharm. 2023 Nov 20;14(4):10.24926/iip.v14i4.5796. doi: 10.24926/iip.v14i4.5796. eCollection 2023.

Authors

Anthony W Olson^{1

2}, Jacob T Brown¹

Affiliations

¹ Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, Minnesota.
² Essentia Institute of Rural Health, Duluth, Minnesota.

Abstract

Both pharmacogenomics (PGx) and the medication experience (MedXp) share a common purpose for their use, which is to optimally tailor medications to each unique individual. The former pursues this aim by using an individual's genetic makeup, while the latter considers the subjective experience of medication-taking in one's life. The different ways by which these fields of study pursue their shared aim have resulted in relatively little understanding of their relationship when utilized in care processes to produce health outcomes. This commentary explores this gap and identifies implications for future research that can help close it to improve person-centered care.

Keywords: Donabedian model; medication adherence; medication experience; medication-taking behaviors; person-centered care; pharmacogenomics.

Publication types

Case Reports